e-learning
resources
Berlin 2008
Monday, 06.10.2008
Novel mechanisms in the pathogenesis of pulmonary inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Contribution of mass spectrometry (SELDI-TOF-MS) to the analysis of low molecular weight proteins in acute and chronic asthma models
F. Quesada Calvo, C. Crahay, R. Maree, D. de Seny, G. Paulissen, M. Gueders, L. Wehenkel, R. Louis, J. M. Foidart, A. Noel, M. Fillet, D. Cataldo (Liege, Belgium)
Source:
Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation
Session:
Novel mechanisms in the pathogenesis of pulmonary inflammation
Session type:
Oral Presentation
Number:
1731
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Quesada Calvo, C. Crahay, R. Maree, D. de Seny, G. Paulissen, M. Gueders, L. Wehenkel, R. Louis, J. M. Foidart, A. Noel, M. Fillet, D. Cataldo (Liege, Belgium). Contribution of mass spectrometry (SELDI-TOF-MS) to the analysis of low molecular weight proteins in acute and chronic asthma models. Eur Respir J 2008; 32: Suppl. 52, 1731
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Mass spectrometry proteomic biomarkers identify acute COPD exacerbations
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
Development of mass spectrometry approaches to quantifying lipid mediators in airway disease
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Metabolic profiling detects biomarkers of protein degradation in COPD patients
Source: Eur Respir J 2012; 40: 345-355
Year: 2012
LSC - 2018 - Characterization of decellularized COPD lung matrices using mass spectrometry proteomics
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Year: 2018
Detection of pregnancy in horses by breath analysis using differential ion mobility spectrometry (DMS)
Source: Annual Congress 2011 - Lung function today and tomorrow I
Year: 2011
Metabolomic fingerprinting of serum samples based on direct infusion mass spectrometry for lung cancer diagnosis
Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors
Year: 2017
Diagnostic accuracy of SELDI-TOF-MS (surface enhanced laser desabsorbtion ionization time of flight mass spectrometry) method in early diagnosis of lung cancer
Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer
Year: 2011
A liquid chromatography MS/MS metabolomics study of COPD patients
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Breath analysis by ion mobility spectrometry allows to discriminate COPD from lung cancer patients.
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018
The application of mass spectrometry to the analysis and characterization of protein and peptide composition in exhaled breath condensate of pneumo-oncological diseased persons
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Quantitative intact proteomics investigations of alveolar macrophages in sarcoidosis
Source: Eur Respir J 2013; 41: 1331-1339
Year: 2013
Adaptation of differential ion mobility spectrometry (DMS) for discrimination of specific biomarkers in exhaled breath in patients with severe renal-pulmonary dysfunction
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Desmosine as a biomarker of elastin degradation in COPD: current status and future directions
Source: Eur Respir J 2008; 32: 1146-1157
Year: 2008
Relationships between body mass index and clinical and functional characteristics in childhood asthma: A cross-sectional analysis
Source: Annual Congress 2011 - Coping and lifestyle in childhood asthma
Year: 2011
Comparison of indirect measurements of multiple breath nitrogen washout with mass spectrometry.
Source: International Congress 2019 – Exploring the lungs in various pathophysiological conditions
Year: 2019
Identification of disease specific biomarkers by exhalomics using Secondary Electrospray Ionisation High-resolution Mass Spectrometry (SESI-HRMS) in children with cystic fibrosis
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018
Clusters of biomarkers in exhaled breath detected by differential ion mobility spectrometry (DMS)
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Ion mobility spectrometry – a new method in the diagnostic approach to sarcoidosis? Preliminary data
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006
Breath analysis by ion mobility spectrometry in COPD and lung cancer patients
Source: Annual Congress 2009 - Quality control in lung function and new developments
Year: 2009
Ion mobility spectrometry in medical diagnostics: proof of inflammation markers in different parliamentary groups of the exhaled breath
Source: Annual Congress 2008 - Assessment of the respiratory system
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept